These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20714866)

  • 1. Clinical significance of a myeloperoxidase gene polymorphism and inducible nitric oxide synthase expression in cirrhotic patients with hepatopulmonary syndrome.
    Wang Y; Wang W; Zhang Y; Zhao X; Yang D
    J Huazhong Univ Sci Technolog Med Sci; 2010 Aug; 30(4):437-42. PubMed ID: 20714866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations of MMP-2 and MMP-9 gene polymorphisms with the risk of hepatopulmonary syndrome in cirrhotic patients: A case-control study.
    Liu JW; Chen DQ
    Kaohsiung J Med Sci; 2018 Nov; 34(11):634-642. PubMed ID: 30392570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal endotoxemia plays a central role in development of hepatopulmonary syndrome in a cirrhotic rat model induced by multiple pathogenic factors.
    Zhang HY; Han DW; Su AR; Zhang LT; Zhao ZF; Ji JQ; Li BH; Ji C
    World J Gastroenterol; 2007 Dec; 13(47):6385-95. PubMed ID: 18081228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of lipopolysaccharides, toll-like receptor and inducible nitric oxide synthase in hepatopulmonary syndrome].
    Yi HM; Wang GS; Cai CJ; Yang Y; Lu MQ; Hu B; Chen GH
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1521-4. PubMed ID: 19953876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diammonium glycyrrhizinate alleviates hepatopulmonary syndrome via restoring superoxide dismutase 3 activity in rats.
    Zhao X; Liu J; Yang S; Chen C; Yin H; Li T; Wang Q; Li X; Lin Y; Cai D
    Eur J Pharmacol; 2017 Jul; 807():144-150. PubMed ID: 28435094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of systemic and pulmonary hemodynamics and plasma levels of inducible nitric oxide synthase and endothelin-1 in patients with hepatopulmonary syndrome].
    Li SR; Shen N; Yi HM; Gan XL; Hei ZQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2030-2. PubMed ID: 19861258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mcp-1, eNOS, tPA and PAI-1 gene polymorphism and correlation of genotypes and phenotypes in hepatopulmonary syndrome.
    Tumgor G; Berdeli A; Arikan C; Levent E; Aydogdu S
    Dig Dis Sci; 2008 May; 53(5):1345-51. PubMed ID: 17934860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of myeloperoxidase in the pathogenesis of postoperative adhesions.
    Saed GM; Jiang Z; Diamond MP; Abu-Soud HM
    Wound Repair Regen; 2009; 17(4):531-9. PubMed ID: 19614918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protective effect of tanshinol on the hepatopulmonary syndrome in rat].
    Jia JT; Zhang HY; Lai LN; Li XJ; Tian XX; Zhang LL; Lv ML; Zhao ZF; Han DW; Cheng J
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 May; 30(3):199-203. PubMed ID: 25244780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome.
    Zhang J; Ling Y; Luo B; Tang L; Ryter SW; Stockard CR; Grizzle WE; Fallon MB
    Gastroenterology; 2003 Nov; 125(5):1441-51. PubMed ID: 14598260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome.
    Rabiller A; Nunes H; Lebrec D; Tazi KA; Wartski M; Dulmet E; Libert JM; Mougeot C; Moreau R; Mazmanian M; Humbert M; Hervé P
    Am J Respir Crit Care Med; 2002 Aug; 166(4):514-7. PubMed ID: 12186830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase serves as a redox switch that regulates apoptosis in epithelial ovarian cancer.
    Saed GM; Ali-Fehmi R; Jiang ZL; Fletcher NM; Diamond MP; Abu-Soud HM; Munkarah AR
    Gynecol Oncol; 2010 Feb; 116(2):276-81. PubMed ID: 19962178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of common NFκB-iNOS pathway by chronic Thalidomide treatment improves Hepatopulmonary Syndrome and Muscle Wasting in rats with Biliary Cirrhosis.
    Li TH; Lee PC; Lee KC; Hsieh YC; Tsai CY; Yang YY; Huang SF; Tsai TH; Hsieh SL; Hou MC; Lin HC; Lee SD
    Sci Rep; 2016 Dec; 6():39405. PubMed ID: 28009008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic determination of TNF and myeloperoxidase production in dialyzed patients with diabetic nephropathy.
    Buraczynska K; Koziol-Montewka M; Majdan M; Tokarz A; Ksiazek A
    Ren Fail; 2004 Nov; 26(6):633-9. PubMed ID: 15600254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ET-1 and TNF-alpha in HPS: analysis in prehepatic portal hypertension and biliary and nonbiliary cirrhosis in rats.
    Luo B; Liu L; Tang L; Zhang J; Ling Y; Fallon MB
    Am J Physiol Gastrointest Liver Physiol; 2004 Feb; 286(2):G294-303. PubMed ID: 14715521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-α neutralization improves experimental hepatopulmonary syndrome in rats.
    Liu L; Liu N; Zhao Z; Liu J; Feng Y; Jiang H; Han D
    Liver Int; 2012 Jul; 32(6):1018-26. PubMed ID: 22672643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of myeloperoxidase promotor polymorphism with cirrhosis in patients with hereditary hemochromatosis.
    Osterreicher CH; Datz C; Stickel F; Hellerbrand C; Penz M; Hofer H; Wrba F; Penner E; Schuppan D; Ferenci P
    J Hepatol; 2005 Jun; 42(6):914-9. PubMed ID: 15885363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepant effects of inducible nitric oxide synthase modulation on systemic and splanchnic endothelial nitric oxide synthase activity and expression in cirrhotic rats.
    Malyshev E; Tazi KA; Moreau R; Lebrec D
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2195-201. PubMed ID: 18031380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of nitric oxide synthase isoforms in human liver cirrhosis.
    Mohammed NA; Abd El-Aleem S; Appleton I; Maklouf MM; Said M; McMahon RF
    J Pathol; 2003 Aug; 200(5):647-55. PubMed ID: 12898602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxyhemoglobin levels in cirrhotic patients with and without hepatopulmonary syndrome.
    Arguedas MR; Drake BB; Kapoor A; Fallon MB
    Gastroenterology; 2005 Feb; 128(2):328-33. PubMed ID: 15685544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.